| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/17/2011 | CN102151336A Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor |
| 08/17/2011 | CN102151330A Vaccine and method for treatment of motor neurone diseases |
| 08/17/2011 | CN102151316A Traditional Chinese medicine composition for treating diabetic peripheral neuropathic pain |
| 08/17/2011 | CN102151306A Active combined product extracted from leechee pulp, preparation method thereof and application thereof |
| 08/17/2011 | CN102151305A Shinyleaf yellowhorn extractive, extraction method thereof and user thereof |
| 08/17/2011 | CN102151280A Application of icariin in preparation of medicine for preventing damage of cortical hormone neuron |
| 08/17/2011 | CN102151274A Method for stable light focusing of fasudil hydrochloride and composition obtained using same |
| 08/17/2011 | CN102151273A 2,4,6-triamino-1,3,5-triazine derivative |
| 08/17/2011 | CN102151268A Compound preparation for treating Alzheimer's disease and preparation method thereof |
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CN102151261A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 08/17/2011 | CN102151258A Application of Alpha-mangostin in preparing medicines for treating Alzheimer's disease |
| 08/17/2011 | CN102151224A Infantile cerebral palsy acupuncture point heat treatment plaster |
| 08/17/2011 | CN102151045A Traditional chinese medicine health-care pillow |
| 08/17/2011 | CN102150859A Composition with functions of relieving physical fatigue and improving memory as well as preparation method and application thereof |
| 08/17/2011 | CN101890104B Chinese medicament for treating neck, shoulder, waist and leg pains |
| 08/17/2011 | CN101785773B Use of metal supermolecular compound in preparation of medicament for treating alzheimer's disease |
| 08/17/2011 | CN101744847B Agaricus compound polysaccharide capsule preparation method |
| 08/17/2011 | CN101716247B Pulvis rhei traditional Chinese medicine compound preparation, preparation method and application thereof |
| 08/17/2011 | CN101716202B Traditional Chinese medicine containing radix achyranthis bidentatae for treating facioplegia as well as preparation method and use |
| 08/17/2011 | CN101703753B Medicinal composition powders or granules for treating whitevein and preparation method thereof |
| 08/17/2011 | CN101703723B Drug-breaking medicine and preparation method thereof |
| 08/17/2011 | CN101703683B Chinese medicinal decoction for treating insomnia |
| 08/17/2011 | CN101693711B 3-(1-piperazinyl)-1,2-benzisothiazole derivative as well as synthesizing method and application thereof |
| 08/17/2011 | CN101647789B Levetiracetam slow release pellet capsule preparation |
| 08/17/2011 | CN101642576B Polyethylene glycol-modified product of KGF-2 and preparation method thereof |
| 08/17/2011 | CN101628090B Narcotic-abstaining addiction-removing traditional Chinese medicine composition, smoking product and preparation method thereof |
| 08/17/2011 | CN101591321B Method for preparing 5,6,7,4'-tetrahydroxyflavone |
| 08/17/2011 | CN101555227B Preparation method of high purity bulleyaconitine A |
| 08/17/2011 | CN101524232B Concave medicine pillow |
| 08/17/2011 | CN101518604B Capsule for treating infantile cerebral palsy and preparation method thereof |
| 08/17/2011 | CN101511367B Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/17/2011 | CN101434660B Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination |
| 08/17/2011 | CN101411758B Chinese medicine solid formulation for treating insomnia and preparation method thereof |
| 08/17/2011 | CN101255136B 5-cyclopropane toroid hydantoin derivatives as well as preparation method and uses thereof |
| 08/17/2011 | CN101172124B Novel uses of pennycress, pharmaceutical composition containing the pennycress and preparation method thereof |
| 08/17/2011 | CN101010296B Piperazine derivatives of alkyhydroxy indole |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors |
| 08/16/2011 | US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2011 | US7998963 Arylpiperazine derivatives and uses thereof |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | US7998503 Form of administration for controlling primary headaches |
| 08/16/2011 | US7998474 Methods for treating an inflammatory disease of the bowel |
| 08/16/2011 | US7997079 Self-regulated thermal energy system |
| 08/16/2011 | CA2629777C Spirocyclic compounds as hdac inhibitors |
| 08/16/2011 | CA2614603C Azolo triazines and pyrimidines |
| 08/16/2011 | CA2587061C Deamidated interferon-beta |
| 08/16/2011 | CA2557163C Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 08/16/2011 | CA2496731C Novel benzonaphthyridines |
| 08/16/2011 | CA2487095C Elongase genes and uses thereof |
| 08/16/2011 | CA2482655C Substituted indoles |
| 08/16/2011 | CA2480275C Statin therapy for enhancing cognitive maintenance |
| 08/16/2011 | CA2468248C Pregnane steroids for use in the treatment of cns disorders |
| 08/16/2011 | CA2450660C Lactone formulations and method of use |
| 08/16/2011 | CA2400639C Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 08/11/2011 | WO2011097581A2 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
| 08/11/2011 | WO2011097336A2 Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor |
| 08/11/2011 | WO2011097181A2 Compositions and methods for re-programming cells without genetic modification for treatment of neurological disorders |
| 08/11/2011 | WO2011097087A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
| 08/11/2011 | WO2011096953A1 Oral antidepressant formulation with reduced excipient load |
| 08/11/2011 | WO2011096728A2 Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096462A1 Heterocyclic compound having npy y5 receptor antagonistic activity |
| 08/11/2011 | WO2011096461A1 Quinoline derivative |
| 08/11/2011 | WO2011096377A1 Pyrrole compound |
| 08/11/2011 | WO2011095803A1 Hplc method for analyzing frovatriptan |
| 08/11/2011 | WO2011095801A2 Pharmaceutical composition |
| 08/11/2011 | WO2011095668A1 Use of yessotoxin and analogues and derivatives thereof for treating and/or preventing neurodegenerative diseases linked to tau and beta amyloid |
| 08/11/2011 | WO2011095593A1 Iodo precursor for a pet imaging agent of amyloid plaques |
| 08/11/2011 | WO2011095585A1 Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| 08/11/2011 | WO2011095579A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates |
| 08/11/2011 | WO2011095434A1 Tetrahydro-pyran derivatives against neurological illnesses |
| 08/11/2011 | WO2011095196A1 Hetaryl-[1,8]naphthyridine derivatives |
| 08/11/2011 | WO2011094864A1 Composition and method for the treatment of neuropathic pain |
| 08/11/2011 | WO2011048612A3 Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof |
| 08/11/2011 | WO2011022606A3 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 08/11/2011 | WO2010100219A3 Pharmaceutical composition containing rasagiline mesylate |
| 08/11/2011 | US20110197294 Compositions and methods for restoring mitochondrial electron transfer function |
| 08/11/2011 | US20110196041 Novel crystal form of calcium 3-acetylaminopropane-1-sulfonate |
| 08/11/2011 | US20110196032 Pharmaceutical Dosage Form of an Antidepressant |
| 08/11/2011 | US20110196028 PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 08/11/2011 | US20110196003 Tricyclic compound and pharmaceutical use thereof |
| 08/11/2011 | US20110195992 New compounds ii |
| 08/11/2011 | US20110195989 Controlled Release Formulations of Opioids |
| 08/11/2011 | US20110195988 Pharmaceutical Composition |
| 08/11/2011 | US20110195983 Quinazolinone derivatives useful as vanilloid antagonists |
| 08/11/2011 | US20110195981 Methods and dosage forms for reducing side effects of benzisozazole derivatives |
| 08/11/2011 | US20110195978 Compounds for treatment of alzheimer's disease |
| 08/11/2011 | US20110195977 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 08/11/2011 | US20110195975 Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 08/11/2011 | US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists |
| 08/11/2011 | US20110195965 Tetrahydro- and dihydroquinazolinones |
| 08/11/2011 | US20110195963 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 08/11/2011 | US20110195960 Inhibitors of c-fms kinase |
| 08/11/2011 | US20110195959 Compositions And Methods Relating To Novel Compounds And Targets Thereof |
| 08/11/2011 | US20110195957 Substituted diazepan orexin receptor antagonists |